Points of Discussion: Topical Medications for the Treatment of Inflammatory Skin Disease in Children

Topical Medications for the Treatment of Inflammatory Skin Disease in Children

Points of Discussion returns with the Atopic Dermatitis and Psoriasis Focused Study Group (FSG). This three-part series delves into topical therapies for treating inflammatory skin diseases in children. Moderator JiaDe (Jeff) Yu, MD, expertly hosts a conversation with two esteemed leaders in atopic dermatitis research: Joy Wan, MD, from Johns Hopkins University School of Medicine, and Peter Lio, MD, PhD, from Northwestern University Feinberg School of Medicine. They discuss various topics, from established therapies to topical steroid withdrawal (TSW), and emerging treatments. Don’t miss this insightful three-part series!

Special thanks to Incyte Pharmaceuticals and Arcutis Biotherapeutics for supporting this independent medical education program. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.

JiaDe (Jeff) Yu, MD

Moderator

Massachusetts General Hospital

Joy Wan, MD

Guest

Johns Hopkins

Peter Lio, MD

Guest

Northwestern Medicine

Guest Disclosures:

Dr. Peter Lio:
Dr. Lio reports being on the speaker’s bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica; reports consulting/advisory boards for Alphyn Biologics (stock options), AbbVie, Almirall, Amyris, Arcutis, ASLAN, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs (stock options), Concerto Biosci (stock options), Dermavant, Eli Lilly, Galderma, Janssen, LEO Pharma, Lipidor, L’Oreal, Merck, Micreos, MyOR Diagnostics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Suneco Technologies (stock options), Theraplex, UCB, Unilever, Verdant Scientific (stock options), Verrica, Yobee Care (stock options). In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member emeritus of the National Eczema Association.

Dr. JiaDe (Jeff) Yu: Dr. Yu has served as a consultant/advisory board/investigator for the following: Abbvie, Arcutis, Astria, Dermavant, iRhythm, Leo, Lilly, National Eczema Association, O’Glacee, Pfizer, Sanofi, Smartpractice, Sol-Gel. He has also receives an honorarium from UptoDate.

Dr. Joy Wan – no disclosures relevant to this discussion.